BioCentury | Jan 26, 2018
Clinical News

CFDA approves EGFR TKI companion diagnostic

...Mark approval in Europe. Amoy Diagnostics Co. Ltd. (SZSE:300685), Xiamen, China Product: Super-ARMS EGFR Mutation Test Business: Diagnostic Alicia Parker Amoy Diagnostics Co. Ltd. Super-ARMS...
BioCentury | Aug 15, 2016
Company News

Amoy Diagnostics, Merck KGaA deal

...Taiwan, Hong Kong, Brazil and Russia, by 2019. The partners did not respond to inquiries. Amoy Diagnostics Co. Ltd....
BioCentury | Nov 2, 2015
Company News

Amoy Diagnostics, Illumina deal

...solid tumors. Illumina declined to disclose financial terms and Amoy did not respond to inquiries. Amoy Diagnostics Co. Ltd....
Items per page:
1 - 3 of 3
BioCentury | Jan 26, 2018
Clinical News

CFDA approves EGFR TKI companion diagnostic

...Mark approval in Europe. Amoy Diagnostics Co. Ltd. (SZSE:300685), Xiamen, China Product: Super-ARMS EGFR Mutation Test Business: Diagnostic Alicia Parker Amoy Diagnostics Co. Ltd. Super-ARMS...
BioCentury | Aug 15, 2016
Company News

Amoy Diagnostics, Merck KGaA deal

...Taiwan, Hong Kong, Brazil and Russia, by 2019. The partners did not respond to inquiries. Amoy Diagnostics Co. Ltd....
BioCentury | Nov 2, 2015
Company News

Amoy Diagnostics, Illumina deal

...solid tumors. Illumina declined to disclose financial terms and Amoy did not respond to inquiries. Amoy Diagnostics Co. Ltd....
Items per page:
1 - 3 of 3